Scienture Holdings, Inc. · NASDAQ:SCNX
Scienture — TRxADE HEALTH — Q2 2022 Earnings Presentation
15 slides from Scienture's earnings presentation, Jul 26, 2022
Slide 1: Digitalizing the Retail Pharmacy Experience
Slide 2: Safe Harbor Statement
Safe Harbor Statement The information set forth herein contains forward-looking statements within the federal securities laws, including the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, Forward-looking statements include all statements that do not relate solely to
Slide 3: About TRxADE HEALTH, INC.
About TRxADE HEALTH, INC. TRxADE is a technology-enabled health services platform company focused on digitalizing the retail pharmacy experience by optimizing drug procurement, the prescription journey and patient engagement in the U.S. * Market Leader: Operates one of the largest technology marketp
Slide 4: Divisions of TRxADE HEALTH
4 Divisions of TRXADE HEALTH Pharmaceutical Marketplaces (With Supporting B2B + Supporting Subsidiaries): | @TRADE HEALTH Supplier-Pharmacy Marketplace Platform Manufacturer-Distributor Marketplace Platform Community SPECIALTY PHARMACY Rx Distributor 1) Pie slices not representative of revenue mix b
Slide 5: TRxADE Marketplace
TRxADE Marketplace Independent Pharmacy and Clinics Our B2B Pharmaceutical Supply Chain Platform Footprint U.S. Pharmaceutical Industry? * Projected $685B per year industry size by 2023 and growing; Over 65,000 Growth TRXADE Registered pharmacy facilities Opportunity’ Users * Approximately 9 out of
Slide 6: TRxADE Marketplace
TRxADE Marketplace = Trxade.com (Distributor Pharmaceutical Supply Chain Platform) Our Marketplace Solution: *TRxADE’s exchange platform offers a clear and concise interface that allows over 13,815+ registered members in 50 states to analyze “up- to-the-minute” supply & pricing from multiple pharma
Slide 7: Selected Operational Metrics
Selected Operational Metrics TRxADE Platform Our marketplace has over 72 national and regional pharmaceutical suppliers providing over 120,000 branded and generic drugs, including over the counter drugs and drugs available for purchase by pharmacists. Metrics for the three month period ending June 3
Slide 8: Marketplace User Supporting Divisions
Marketplace User Supporting Divisions Ca Ua BONUM HEALTH Bonum Health Tele Health Company offers individual and Employer sponsored patients access to certified medical providers 24/7/365 in 50 states * Focus on uninsured and underinsured patients * Has Partnerships with 1,000+ Retail chain and indep
Slide 9: Selected Financials
Selected Financials * High Margin: Revenue from transaction fees on marketplace platform (Credit Card/PayPal model) does not include the drugs value (over $100M annually), hence “tech like margins” * Built-Out Platform: 13,815+ registered members with continued platform development requiring minimal
Slide 10: Management
Management Suren Ajjarapu, Chairman of the Board and Chief Executive Officer Mr. Ajarapu has served as Chairman of the Board, Chief Executive Officer and Secretary since our acquisition of Trxade Group, Inc., a Nevada corporation (“TRxADE Nevada”) (our predecessor company) on January 8, 2014, and as
Slide 11: Key Takeaways
ala Key Takeaways NASDAQ:MEDS TRXADE is a technology-enabled health services platform company focused on digitalizing the retail pharmacy experience by optimizing drug procurement, the prescription journey and patient engagement in the U.S. A Tech Focused Healthcare Services Company Market Leader: O
Slide 12: Contact Us
12 Contact Us TRxADE HEALTH, INC. 2420 Brunello Trace Lutz , FL 34558 (800) 261-0281 www.trxadehealth.com @TRADE
Slide 13: Consolidated Balance Sheets
‘TRxADE HEALTH, INC. Consolidated Balance Sheets June 30, 2022 and December 31, 2021 Sune 30, December 31, 2022 2001 Assets Current Assets Cash S 90227 $3258 Accounts receivable, net 1.019.068, 978.73 Inventory 12739 36279 Prepaid assets 363.603 216414 Inventory deposits 875321 Total Curent Assets 3
Slide 14: Consolidated Statement of Operations
TRXADE HEALTH, INC. Consolidated Statement of Operations For the Three and Six months Ended June 30, 2022 and 2021 Three Months Ended June 30, Six Months Ended June 30, 2022 2021 2022 2021 Revenues Ss 3278729 $ 1.898254 S$ 6519001 $ 4,951,489 Cost of Sales 2,107,813 1,056,863 4.012.384 2,726,187 Gro
Slide 15: Reconciliation of Net Income (Loss) to Adjusted EBITDA
Reconciliation of Net Income(Loss) attributable to TRKADE HEALTH, Inc., to Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA) and Adjusted EBITDA* For the three months ended For the six months ended June 30, June 30, 2022 2021 2022 2021 Net Income (Loss) attributable to TRxADE H